| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |